Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126135431 | 12613543 | 1 | I | 20160719 | 20160802 | 20160802 | EXP | PL-ROCHE-1806367 | ROCHE | HRENCZUK M, SOWINSKA R, TRONINA O, MALKOWSKI P, DURLIK M, PACHOLCZYK M ET AL. NURSING PROBLEMS IN CARE OF A PATIENT WITH VERY EARLY HCV INFECTION RECURRENCE AFTER LIVER TRANSPLANTATION: A CASE REPORT. ANNALS OF TRANSPLANTATION 2016;21:400-407. | 22.00 | YR | F | Y | 0.00000 | 20160802 | MD | PL | PL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126135431 | 12613543 | 1 | PS | RIBAVIRIN. | RIBAVIRIN | 1 | Unknown | U | 21511 | 600 | MG | BID | |||||||
| 126135431 | 12613543 | 2 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Unknown | 400 + 600 MG/DAY | U | 21511 | |||||||||
| 126135431 | 12613543 | 3 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Unknown | U | 21511 | 600 | MG | BID | |||||||
| 126135431 | 12613543 | 4 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Unknown | U | 21511 | 400 | MG | BID | |||||||
| 126135431 | 12613543 | 5 | SS | Peg-Interferon Alfa 2a | PEGINTERFERON ALFA-2A | 1 | Unknown | U | 103964 | 180 | UG | /wk | |||||||
| 126135431 | 12613543 | 6 | SS | Peg-Interferon Alfa 2a | PEGINTERFERON ALFA-2A | 1 | Unknown | U | 103964 | 135 | UG | /wk | |||||||
| 126135431 | 12613543 | 7 | SS | Peg-Interferon Alfa 2a | PEGINTERFERON ALFA-2A | 1 | Unknown | 90-135MCG/WEEK | U | 103964 | /wk | ||||||||
| 126135431 | 12613543 | 8 | SS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Unknown | 50722 | |||||||||||
| 126135431 | 12613543 | 9 | SS | TELAPREVIR | TELAPREVIR | 1 | Unknown | 0 | 750 | MG | TID | ||||||||
| 126135431 | 12613543 | 10 | SS | SOFOSBUVIR | SOFOSBUVIR | 1 | Unknown | 0 | |||||||||||
| 126135431 | 12613543 | 11 | C | TACROLIMUS. | TACROLIMUS | 1 | Unknown | 0 | .5 | MG | QD | ||||||||
| 126135431 | 12613543 | 12 | C | TACROLIMUS. | TACROLIMUS | 1 | Unknown | 0.5 MG+1MG | 0 | QD | |||||||||
| 126135431 | 12613543 | 13 | C | PREDNISONE. | PREDNISONE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126135431 | 12613543 | 1 | Hepatitis C |
| 126135431 | 12613543 | 5 | Hepatitis C |
| 126135431 | 12613543 | 8 | Immunosuppression |
| 126135431 | 12613543 | 9 | Antiviral treatment |
| 126135431 | 12613543 | 10 | Antiviral treatment |
| 126135431 | 12613543 | 11 | Immunosuppression |
| 126135431 | 12613543 | 13 | Immunosuppression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126135431 | 12613543 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126135431 | 12613543 | Anaemia | |
| 126135431 | 12613543 | Anal pruritus | |
| 126135431 | 12613543 | Hypogammaglobulinaemia | |
| 126135431 | 12613543 | Leukopenia | |
| 126135431 | 12613543 | Neutropenia | |
| 126135431 | 12613543 | Pancytopenia | |
| 126135431 | 12613543 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |